@drjohnm @HH4EHRA @jskoruth Thank you from me too and yes, I agree with John! Direct link to editorial here: looking forward to hearing what others think.
Pulsed Field Ablation for Persistent Atrial Fibrillation (PersAFOne): Hope or Hype?
Mentions
Extended reach
Total likes
Video views
Mentions per month
Aug 2020 – May 2025Where it's discussed
-
X / Twitter11 posts
-
Bluesky2 posts
-
YouTube2 videos
AI synopsis
What people are saying
The strong interest and engagement are evidenced by posts praising PFA's high success rates and patient outcomes, like '99.7% procedural success,' while also debating safety concerns, such as brain white matter lesions. The tone shifts from optimistic to cautious, illustrating how the discussions are balancing hope with critical analysis of safety and long-term effects.
Most discussions recognize the promising results of PFA, especially noting its high success rate and potential benefits, though some express caution about safety concerns.
The conversations demonstrate high curiosity, especially around clinical outcomes and safety issues, indicating strong engagement with the topic.
Participants reference specific studies, clinical outcomes, and safety issues, showing they are actively analyzing and debating the findings.
The discussions suggest the article has a meaningful influence, prompting further dialogue about PFA’s safety, effectiveness, and future potential.
Abstract in brief
- The document discusses Pulsed Field Ablation (PFA) as a new treatment for persistent atrial fibrillation (PersAF), emphasizing its potential advantages over traditional methods like thermal ablation, such as being quicker and more tissue-selective.
- It reviews current research and clinical trials, highlighting both promising results in terms of safety and efficacy, and the need for further studies to confirm PFA's long-term benefits and optimal application techniques.
- The text balances optimism about PFA's potential with caution, suggesting that while it offers hope for better management of PersAF, more evidence is needed before it can become a standard treatment.]
Top posts
Most liked on X and BlueskyPulsed Field Ablation for persistent atrial fibrillation achieved 99.7% procedural success and 85.3% patient freedom from symptoms after one year. by Reddy VY, Gerstenfeld EP (...) Mansour M et 31 al. in J Am Coll Cardiol #MedSky
Two authors worried about this issue 3 years ago in the pages of JACC https://t.co/avhukw9uoG cc @DRTomlinsonEP https://t.co/dCZU3BCpTa
PFA has great potential, but we must be careful about its safety--especially in the brain As it were @DRTomlinsonEP and I have opined on this issue/ https://t.co/BzZgn8RYdr #WAFib2021 https://t.co/cU85va2D5L https://t.co/BF40JSCiFd
@DrAJRestrepo @KashifMD @LuigiDiBiaseMD @EuropaceEiC @GiulioConte9 @Dominik_Linz @AndyZhangMD @marcovitoloMD @MBergonti @FraSantoroMD @drjohnm @atulverma_md @mcfinlay Fully covered here, along with @drjohnm Most troubling, was the fact that these investigators set themselves the task of validating the extent of brain white matter lesions with CMR, & then performed precisely zero scans in the very next study Why? https://t.co/YZUgrS1MH1
Pulsed Field Ablation for Persistent Atrial Fibrillation: 1-Year Results of ADVANTAGE AF
All mentions
Pulsed Field Ablation for Persistent Atrial Fibrillation: Promise and Challenges
This video discusses Pulsed Field Ablation as a new treatment for persistent atrial fibrillation, highlighting its potential advantages over traditional methods and examining current research and clinical trials for…
Review of VT Ablation: Comparing Catheter Ablation and AADs
This podcast critiques comments on VT ablation while reviewing EHRA presentations. The SURVIVE-VT trial findings suggest catheter ablation shows better outcomes after 24 months compared to antiarrhythmic drugs. Join…
Pulsed Field Ablation for persistent atrial fibrillation achieved 99.7% procedural success and 85.3% patient freedom from symptoms after one year. by Reddy VY, Gerstenfeld EP (...) Mansour M et 31 al. in J Am Coll Cardiol #MedSky
Pulsed Field Ablation for Persistent Atrial Fibrillation: 1-Year Results of ADVANTAGE AF
@DrAJRestrepo @KashifMD @LuigiDiBiaseMD @EuropaceEiC @GiulioConte9 @Dominik_Linz @AndyZhangMD @marcovitoloMD @MBergonti @FraSantoroMD @drjohnm @atulverma_md @mcfinlay Fully covered here, along with @drjohnm Most troubling, was the fact that these investigators set themselves the task of validating the extent of brain white matter lesions with CMR, & then performed precisely zero scans in the very next study Why? https://t.co/YZUgrS1MH1
RT @drjohnm: Two authors worried about this issue 3 years ago in the pages of JACC https://t.co/avhukw9uoG cc @DRTomlinsonEP
RT @drjohnm: Two authors worried about this issue 3 years ago in the pages of JACC https://t.co/avhukw9uoG cc @DRTomlinsonEP
Two authors worried about this issue 3 years ago in the pages of JACC https://t.co/avhukw9uoG cc @DRTomlinsonEP https://t.co/dCZU3BCpTa
PFA has great potential, but we must be careful about its safety--especially in the brain As it were @DRTomlinsonEP and I have opined on this issue/ https://t.co/BzZgn8RYdr #WAFib2021 https://t.co/cU85va2D5L https://t.co/BF40JSCiFd
RT @DRTomlinsonEP: @drjohnm @HH4EHRA @jskoruth Thank you from me too and yes, I agree with John! Direct link to editorial here: looking for…
RT @DRTomlinsonEP: @drjohnm @HH4EHRA @jskoruth Thank you from me too and yes, I agree with John! Direct link to editorial here: looking for…
RT @DRTomlinsonEP: @drjohnm @HH4EHRA @jskoruth Thank you from me too and yes, I agree with John! Direct link to editorial here: looking for…
@drjohnm @HH4EHRA @jskoruth Thank you from me too and yes, I agree with John! Direct link to editorial here: looking forward to hearing what others think.
Pulsed Field Ablation for Persistent Atrial Fibrillation (PersAFOne): Hope or Hype? - https://t.co/AwsZHeX5B5 https://t.co/JZ9QSQt2XW
Pulsed Field Ablation for Persistent Atrial Fibrillation (PersAFOne): Hope or Hype? https://t.co/8umyFkIVIp #Cardiology #JACC
DT
JM
B
TM
TA
D
I